1.Intramuscular injection of human umbilical cord mesenchymal stem cells and its effect on the cardiac function and myocardial ultrastructure in rats with Adriamycin-induced dilated cardiomyopathy rats
Benzhen WANG ; Chenggang MAO ; Rong LI ; Xianfeng NING ; Zipu LI
Chinese Journal of Applied Clinical Pediatrics 2016;(1):28-32
Objective To explore the effects of intramuscular injection human umbilical cord mesenchymal stem cells(hUCMSC)intramuscular injection on the cardiac function and myocardial ultrastructure in rats with Adria-mycin -induced dilated cardiomyopathy (DCM)rats.Methods One hundred and sixty rats were randomly divided in-to a normal group (20 cases)and DCMgroups (1 40 cases),rats in DCMgroups receiving Adriamycin (2 mg/kg)in-traperitoneally once a week for 8 weeks to establish DCM models.The DCM rats were randomly divided into a model control group (served as model group),the supernatant of hUCMSC group (served as supernatant group),the low -dose hUCMSC group(served as low -dose group),the medial -dose hUCMSC group(served as medial -dose group), and the high -dose hUCMSC group(served as high -dose group).Echocardiography was performed to evaluate the car-diac function,plasma brain natriuretic peptide (BNP)level and serum cardiac troponin I (cTnI)level were detected by enzyme -linked immunosorbent assay kit;light microscope and transmission electron microscopy (TEM)were used to observe the ultrastructure of myocardium.Results Rats in the DCM group showed low spirit,declining food intake, progressive emaciation,slow growth,hair loss and ascites.After the intramuscular injection of hUCMSC,the above symp-toms of rats in the low -dose and the medial -dose hUCMSC groups were improved significantly.Before the administra-tion of hUCMSC,the left ventricular ejection fraction (LVEF)[(64.53 ±2.61 )%]and the left ventricular fractional shortening (LVFS)[(30.80 ±2.1 1 )%]were significantly decreased in the DCMgroup compared to those of the con-trol group[(79.67 ±3.02 )%,(43.08 ±3.1 5 )%,all P <0.01 ].After the administration of hUCMSC,LVEF [(75.5 ±7.4)%,(74.0 ±6.1 )%]and LVFS[(40.8 ±3.8)%,(40.2 ±5.0)%]were significantly increased in the low -dose and the medial -dose group compared with those of the model group [(65.8 ±4.5)%,(30.2 ± 2.9)%,all P <0.01 ].The concentration of plasma BNP level [(438.3 ±82.2)ng/L,(341 .7 ±68.9)ng/L]and serum cTnI level [(375.9 ±1 1 0.9)ng/L,(355.9 ±55.6)ng/L]were significantly decreased compared with those of the model group [(449.9 ±91 .8)ng/L,(425.9 ±42.6)ng/L,all P <0.05].The findings of HE staining showed that cardiomyocytes were orderly arranged,edema decreased and cell nucleus homogeneously stained in the low -dose and the medial -dose group.The outcomes of TEM revealed that the ultrastructure of cardiomyocytes was improved in the low -dose and the medial -dose group compared with that of model group,and the cardiomyocyte sarcolemma re-mained intact,and the swelling of mitochondria ameliorated and the cristae of mitochondria remained clear.Conclusions Intramuscular injection of hUCMSC could significantly increase LVEF and LVFS in the Adriamycin -induced DCM rats,and decrease the plasma BNP levels and the serum cTnI levels,attenuate the myocardial pathological damage and improve myocardial ultrastructure.
2.Human umbilical cord mesenchymal stem cells via intramuscular injection influence the expression of cytokines related to dilated cardiomyopathy in rats
Yanjie JIANG ; Chenggang MAO ; Xianfeng NING ; Rong LI ; Zipu LI
Chinese Journal of Tissue Engineering Research 2015;(14):2179-2185
BACKGROUND:Studies have shown that intramuscular transplantation of xenogeneic umbilical cord mesenchymal stem cel s in a certain dose range is safe and reliable, and it also confirm that this approach is equal y safe and effective for heart failure in rats with dilated cardiomyopathy. OBJECTIVE:To explore the effect of human umbilical cord mesenchymal stem cel s through intramuscular injection on the cytokine expression in adriamycin-induced dilated cardiomyopathy (DCM) rats. METHODS:Total y 160 rats were randomly divided into control group (n=20) and DCM group (n=140). Rats in the DCM group were administered adriamycin intraperitoneal y to establish DCM model. The DCM rats were randomly subdivided into model control group (served as model group), cel supernatant group, the low-dose mesenchymal stem cel group (served as low-dose group), the middle-dose mesenchymal stem cel group (served as middle-dose group), and the high-dose mesenchymal stem cel s group (served as high-dose group). Secondary injection was performed at 4 weeks after first injection. RESULTS AND CONCLUSION:The ELISA test showed that the serum levels of vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), leukemia inhibitor factor (LIF) and granulocyte macrophage colony stimulating factor (GM-CSF) were higher in the model group than the control group before and after intramuscular injection (P<0.05). After intramuscular injection, the levels of HGF, LIF, GM-CSF and VEGF in the low-dose group were increased significantly (P<0.05), which were significantly higher than those in the model group (P<0.05). The level of LIF in the middle-dose group was significantly elevated after injection (P<0.05), while there were no significant differences in HGF, VEGF and GM-CSF levels in the high-dose group before and after intramuscular injection (P>0.05). Both the immunohistochemical and RT-PCR results showed that the expressions of insulin-like growth factor-1, VEGF and HGF were increased in al the DCM rats as compared with the control group, which were increased most in the middle-dose group. These findings indicate that low-dose and middle-dose human umbilical cord mesenchymal stem cel s intramuscular injection can increase the serum levels of HGF, LIF, GM-CSF, VEGF and the expressions of IGF-1, HGF and VEGF in the myocardium of DCM rats.
4.Diagnose and treatment of adrenal myelolipoma
Shi RONG ; Bingbing SHI ; Zhigang JI ; Quanzong MAO ; Hanzhong LI
Basic & Clinical Medicine 2006;0(02):-
Objective To review the diagnosis and treatment of adrenal myelolipoma(ML).Methods The medical records of 21 patients with adrenal myelolipoma were reviewed.All patients were examined by B-ultrasound,CT and endocrine tests while some were also examined by MRI and 131I-MIBG.Results All patients had undergone resection of adrenal ML.The mean diameter of tumors was 6.7 cm(4.5 cm~12 cm).Pathological examination of all tumors confirmed the diagnosis of adrenal ML.No recurrence was recorded during the follow-up period(1~15years).Conclusion Adrenal ML is a kind of rare,benign tumor and is often incidentally discovered.Its prognosis is generally good.
5.Discussion of anti-inflammatory mechanism of cyclooxygenase (COX-2) inhibitor in improving cardiovascular safety.
Jin-Long MAO ; Xiao-Yu LI ; Rong SUN
China Journal of Chinese Materia Medica 2014;39(20):4054-4059
The new generation cyclooxygenase (COX-2) inhibitor could reduce the gastrointestinal side effect of NSAID drugs, but eventually increase the cardiovascular risk, because its selective inhibition of COX-2 induces the imbalance between PGI2 and TXA2 and the reduction of vasodilatory NO. Under pathological conditions, active oxygen species (O2-*2, etc) were used to induce endo- thelial dysfunction, activate NF-κB to induce expressions of pro-inflammatory cytokines IL-1β and TNF-α, increase ET-1, TXA2 with vasoconstrictor effect, reduce PGI2 and NO with vasodilatory effect, generate further oxidative damage together with NO, and reduce the bioavailability of NO. NO-NSAIDs and NO-Coxibs drugs raised the level of NO by introducing NO-donor (ONO2). NSAIDs drugs enhanced the anti-inflammatory activity of COX-2 and reduced gastrointestinal side effects by inhibiting selectively COX-2. If antioxidant structures with active ingredients of traditional Chinese medicines were introduced to improve the antioxidant activity of NSAIDs, they could scavenge the active oxygen species to protect the normal function of vascular endothelia and enhance the bioavailability of NO, which is conducive to enhance the cardiovascular safety of cyclooxygenase (COX-2) inhibitor.
Anti-Inflammatory Agents
;
therapeutic use
;
Biomarkers, Pharmacological
;
Cardiovascular Diseases
;
drug therapy
;
enzymology
;
immunology
;
Cyclooxygenase 2
;
immunology
;
Cyclooxygenase 2 Inhibitors
;
adverse effects
;
therapeutic use
;
Drugs, Chinese Herbal
;
therapeutic use
;
Humans
;
NF-kappa B
;
immunology
;
Reactive Oxygen Species
;
immunology
;
Tumor Necrosis Factor-alpha
;
immunology
6.Take hoarseness as the cardinal symptom of one thoracic aortic aneurysm case.
Xiang-dong LI ; Xin-rong YAN ; Mao LÜ
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2011;46(12):1043-1043
Adult
;
Aortic Aneurysm, Thoracic
;
complications
;
diagnosis
;
Hoarseness
;
diagnosis
;
etiology
;
Humans
;
Male
7.A Cross-sectional Study on Diabetes Mellitus in Rural Population in Kunming
Mao-Rong ZHANG ; Lan SHEN ; Zhi-Kun LI
Chinese Journal of Prevention and Control of Chronic Diseases 2006;0(06):-
Objective To study the epidemiological characteristics of diabetes mellitus and to provide effective prevention and intervention methods in rural area in Kunming.Methods A cross-sectional study was conducted among 3 440 permanent residents aged 20~74 years in kunming rural districts.Results The general prevalence rate of diabetes was 4.01% and the standardized rate was 2.90%.The standardized prevalent rate for male(3.55%) was higher than that for female(2.61%),and the prevalence rates varied among different groups of rural inhabitants.Conclusion It is necessary to take effective methods to prevent and control diabetes in rural area.
8.Granuloma-like interdigitating dendritic cell sarcoma: report of a case.
Rong-jun MAO ; Xiong-zeng ZHU ; Qi-ming LI ; Hui-qiong FANG
Chinese Journal of Pathology 2012;41(2):134-136
Antigens, CD
;
metabolism
;
Antigens, Differentiation, Myelomonocytic
;
metabolism
;
Dendritic Cell Sarcoma, Follicular
;
metabolism
;
pathology
;
Dendritic Cell Sarcoma, Interdigitating
;
metabolism
;
pathology
;
surgery
;
Diagnosis, Differential
;
Granuloma
;
metabolism
;
pathology
;
surgery
;
Head and Neck Neoplasms
;
metabolism
;
pathology
;
surgery
;
Humans
;
Leukocyte Common Antigens
;
metabolism
;
Lymph Nodes
;
metabolism
;
pathology
;
Lymphoma, Large-Cell, Anaplastic
;
metabolism
;
pathology
;
Lymphoma, T-Cell
;
metabolism
;
pathology
;
Male
;
Middle Aged
;
Neoplasms, Multiple Primary
;
metabolism
;
pathology
;
surgery
;
Receptors, Cell Surface
;
metabolism
;
S100 Proteins
;
metabolism
;
Tonsillar Neoplasms
;
metabolism
;
pathology
;
secondary
9.Inclusion body fibromatosis: report of a case.
Rong-jun MAO ; Hui-qiong FANG ; Bin HE ; Qi-ming LI
Chinese Journal of Pathology 2012;41(1):52-53
Calcium-Binding Proteins
;
metabolism
;
Diagnosis, Differential
;
Female
;
Fibroma
;
metabolism
;
pathology
;
surgery
;
Humans
;
Inclusion Bodies
;
pathology
;
Infant
;
Microfilament Proteins
;
metabolism
;
Skin Neoplasms
;
metabolism
;
pathology
;
surgery
;
Soft Tissue Neoplasms
;
pathology
;
Tendons
;
pathology
;
Toes
;
Vimentin
;
metabolism
10.Lipidized fibrous histiocytoma: report of a case.
Rong-jun MAO ; Jian WANG ; Hui-qiong FANG ; Qi-ming LI
Chinese Journal of Pathology 2012;41(1):50-51
Antigens, CD
;
metabolism
;
Antigens, Differentiation, Myelomonocytic
;
metabolism
;
Diagnosis, Differential
;
Histiocytoma, Benign Fibrous
;
metabolism
;
pathology
;
surgery
;
Humans
;
Male
;
Middle Aged
;
Neprilysin
;
metabolism
;
Receptors, Cell Surface
;
metabolism
;
Skin Neoplasms
;
metabolism
;
pathology
;
surgery
;
Thigh
;
Vimentin
;
metabolism